emerging-tech-investing DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation
emerging-tech-investing DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress
emerging-tech-investing DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence Scientist to Accelerate our Innovation in Healthcare
emerging-tech-investing Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital
emerging-tech-investing Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital
emerging-tech-investing DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025
emerging-tech-investing DIAGNOS Announces $2.0 Million Brokered Private Placement Led by Centurion One Capital
emerging-tech-investing DIAGNOS Strengthens Governance and Leadership with the Appointment of Philippe Couillard as Chairman of the Board of Directors
emerging-tech-investing DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 2025
emerging-tech-investing Validated for Global Scale: DIAGNOS Passes Annual MDSAP Audit, Solidifying the Pathway to Approvals with Health Canada & FDA
African Discovery Group announces signing of Definitive Sales and Purchase Agreement for Butembo Copper Asset in the Democratic Republic of Congo; name change to Copper Intelligence, Inc
Saga Metals Acknowledges U.S. Strategic Critical Minerals Reserve "Project Vault" and Highlights Titanium's Strategic Importance to North American Defense Supply Chains
Blackrock Silver to Present at the Precious Metals and Critical Minerals Virtual Investor Conference on February 10th 2026
